File this under “Let’s agree to disagree.”
Last June, the US Food and Drug Administration inspected a plant in India run by USV, which makes medicines and pharmaceutical ingredients, and found several manufacturing violations. These were detailed in a March 10 warning letter the agency sent to the company.
About the Author Reprints
Harmonization is tough. Apparently they couldn’t come to terms on the maximum allowable number of rodent pellets per square foot of floor space.